SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as chatter focuses on Donald Trump's alleged connections to the Epstein case, with community members debating the validity and implications of related documents. Some are defending Trump, claiming the accusations are a hoax, while others criticize his associations and economic policies. The stock's performance and broader economic concerns under the current administration are also being discussed.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming staking updates and airdrop details, creating excitement. The community buzzes about token burns, achieving new milestones, and the potential for future utilities. Brokecoin continues to gain traction within the Solana meme coin ecosystem, fueled by a dedicated community and ongoing development efforts.

Memecoin on Injective taken over by the community.

Nonja

Nonja ($NONJA.X) is trending as community members express strong bullish sentiment, touting its potential for significant gains and highlighting its strong community. Community members emphasize $NONJA.X's solid presence within the Injective ($INJ.X) ecosystem, where it is the leading memecoin, noting its unique features and potential to outperform $INJ.X itself.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to takeover speculation fueled by a Betaville rumor mentioning a large American pharmaceutical company as a potential suitor. The community is discussing the validity of the rumor and comparing the stock's potential to previous significant runs in the biotech sector. Some investors hope for a buyout, while others prefer the company to remain independent for further growth.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL.X is trending following news of the Solana memecoin officially acquiring rights to the Trollface meme, leading to a surge in market cap. The community is discussing its potential for significant gains, drawing comparisons to other successful meme coins and highlighting its strong community. Some users are also pointing to $GASH.X as another coin with similar potential.

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Align Technology, Inc.

ALGN is trending as the community discusses recent price movement and future prospects, with some users drawing comparisons to SmileDirectClub's bankruptcy. Bullish investors point to share buybacks and insider buying as potential catalysts, while bears cite concerns about competition and market saturation. Discussions also include potential price targets and reactions to news from analysts.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAL is trending as the community discusses its potential in early cancer detection, highlighted by a recent article and a story about its life-saving importance. Some traders are taking profits, anticipating a retest, while others see long-term potential, particularly with possible FDA approval and broader access to its Galleri test. Volume and news catalysts are key talking points for future price movement.

USELESS

$USELESS.X is gaining attention, with community members highlighting the potential for significant gains, referencing a possible 2000% move. Bullish sentiment seems to be driven by the coin's low market cap and community excitement around its potential, especially compared to other memecoins. Some users suggest that whales are accumulating $USELESS.X, anticipating a substantial pump.

WorldFinancial

World Liberty Financial (WLFI.X) is trending as the community discusses its potential role in revolutionizing finance, particularly through its USD1 stablecoin and tokenized real estate initiatives, with some highlighting potential conflicts involving Justin Sun. Community members are debating the token's long-term prospects, its ties to the Trump family, and its relationship with ALTS.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce selected it to verify and distribute economic data onchain. The community is discussing its potential to disrupt the oracle space and integrate with DeFi protocols, drawing comparisons to Chainlink and CRO. Some users are speculating on price targets and anticipating the next leg up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Senti Biosciences Inc. skyrocketed over 400% on Monday afternoon, making it the top gainer across U.S. stock exchanges and the top trending ticker on Stocktwits.&nbsp;The surge was fueled by the biotech company’s announcement of an oversubscribed private placement and promising early clinical data for its experimental blood cancer treatment.&nbsp;The stock rallied to levels last seen in April 2023, drawing significant attention from retail investors.Senti disclosed that it had entered into a securities purchase agreement with existing and new accredited investors to raise approximately $37.6 million through the sale of Series A&nbsp;convertible preferred stock in a private investment in public equity (PIPE) financing.&nbsp;The deal includes warrants allowing investors to purchase up to an additional 25,069,500 shares of the company’s common stock, contingent on shareholder approval.&nbsp;Additionally, an option was granted to a specific investor to buy 4,444 more shares of preferred stock and accompanying warrants, potentially generating $10 million more in gross proceeds by Dec. 27.The PIPE financing, led by Celadon Partners and supported by institutional players like New Enterprise Associates, Leaps by Bayer, and Nantahala Capital, is expected to close by Thursday.&nbsp;Senti plans to use the proceeds to advance its SENTI-202 program, scale manufacturing capabilities, support ongoing R&amp;D efforts, and for general corporate purposes.Positive clinical data from the Phase 1 trial of SENTI-202 also contributed to the stock’s meteoric rise.&nbsp;The trial focused on treating acute myeloid leukemia and other relapsed or refractory hematologic cancers using Senti’s proprietary gene circuit technology.&nbsp;Initial results revealed that two of three treated patients achieved complete remission, confirmed by bone marrow biopsy, with both patients remaining in remission for three and four months, respectively.&nbsp;The treatment was reported to have a generally well-tolerated safety profile at the administered dose, with further trial updates expected next year as dose escalation continues.<figure class="image"><a href="https://stocktwits.com/symbol/SNTI"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/SNTI_sentiment_meter_and_message_volume_on_Dec_2_42660f4d88.png" alt="SNTI sentiment meter and message volume on Dec 2.png" width="1314" height="320"></a><figcaption>SNTI sentiment meter and message volume on Dec 2 as of 1:00 pm ET | source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment for SNTI turned ‘extremely bullish’ amid soaring message volume.<stembedurl>https://stocktwits.com/DJTAZ/message/594734529</stembedurl><stembedurl>https://stocktwits.com/Pianomemo/message/594734011</stembedurl>Year-to-date, Senti Biosciences shares have gained over 70%, with Monday’s explosive rally marking a pivotal moment for the company’s visibility in the biotech sector.For updates and corrections email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-rises-after-upgrade-price-target-hikes/cJ9kq43RhE">Tesla Stock Rises After Massive Price Target Hikes On Trump, AI Factors: Retail’s Charged Up</a>

Senti's deal includes warrants allowing investors to purchase up to an additional 25,069,500 shares of the company’s common stock

Senti Biosciences Skyrockets 400% On Oversubscribed PIPE Deal, Promising Cancer Trial Data: Retail Overjoyed

The stock rallied to levels last seen in April 2023, drawing significant attention from retail investors.

Equity

Wolf Popper LLP Announces Investigations on Behalf of Investors in Materially Underperforming Special Purpose Acquisition Companies

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of investors in the following Special Purpose Acquisition Companies (SPAC). The stock prices...

SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
The post SNTI...

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second quarter of 2024 Cash and anticipated...

Short Interest in Senti Biosciences, Inc. (NASDAQ:SNTI) Decreases By 21.9%

Senti Biosciences, Inc. (NASDAQ:SNTI  Get Free Report) saw a large drop in short interest in the month of February. As of February 29th, there was short interest totalling 269,900 shares, a...

Head to Head Review: Senti Biosciences (NASDAQ:SNTI) versus ZIVO Bioscience (NASDAQ:ZIVO)

Senti Biosciences (NASDAQ:SNTI  Get Free Report) and ZIVO Bioscience (NASDAQ:ZIVO  Get Free Report) are both small-cap medical companies, but which is the better investment? We will...

Senti Biosciences (NASDAQ:SNTI) & X4 Pharmaceuticals (NASDAQ:XFOR) Head to Head Analysis

Senti Biosciences (NASDAQ:SNTI  Get Free Report) and X4 Pharmaceuticals (NASDAQ:XFOR  Get Free Report) are both small-cap medical companies, but which is the better business? We will...

Senti Biosciences to reduce workforce by 37%

Senti Biosciences to reduce workforce by 37...

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1 clinical trial of SENTI-202 expected in 2H 2024...

Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight challenging diseases. The company was founded by Timothy K. Lu, Wilson Wong, and Philip Lee on June 9, 2016 and is headquartered in South San Francisco, CA.

SNTI
Senti Biosciences Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest SNTI News

SNTI Senti Biosciences Inc.